Safety of a trastuzumab biosimilar, used under routine clinical practice conditions in adult HER2+ breast cancer patients in Morocco.

Hassan Errihani,Narjiss Berrada,Mouna Khouchani,A Acharki,Kamal Lahbabi,Hassan Jouhadi,Meryem Glaoui

Safety of a trastuzumab biosimilar, used under routine clinical practice conditions in adult HER2+ breast cancer patients in Morocco.

2020

Hassan Errihani
Narjiss Berrada
Mouna Khouchani
A Acharki
Kamal Lahbabi
Hassan Jouhadi
Meryem Glaoui

e13024Background: Hertraz, the first trastuzumab biosimilar was approved in Morocco in 2017. Real world data on trastuzumab biosimilars are very limited or not available. HERLife is a prospective, ...

Keywords:

routine clinical practice
Trastuzumab
Physical therapy
Oncology
Breast cancer
Internal medicine
Medicine
Biosimilar
real world data
Intensive care medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations